MedPath

The effect of zinc supplement on control status of diabetes in diabetic Patients

Not Applicable
Conditions
Diabetes.
Diabetes mellitus
E10, E11,
Registration Number
IRCT138812212676N2
Lead Sponsor
Diabetes center of Yazd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Age 40-60, HbA1c greater than 7, TG Less than 400 mg/dl, Cho Less than 250 mg/dl .
Exclusion criteria: Smoking, using antioxidant drug, using insulin and renal disease

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
HbA1C. Timepoint: 1 Month prior to intervention, 2 Month after intervention. Method of measurement: Cell counter instrument.
Secondary Outcome Measures
NameTimeMethod
Fasting blood sugar and 2 hours postprandial. Timepoint: 1 Month prior to intervention, 2 Month after intervention. Method of measurement: Photometer instrument.;Serum Zinc level. Timepoint: 1 Month prior to intervention, 2 Month after intervention. Method of measurement: ELIZA.
© Copyright 2025. All Rights Reserved by MedPath